期刊文献+

精神分裂症患者手术治疗前后海马磁共振质子波谱成像的研究 被引量:2

Proton magnetic resonance spectroscopic imaging of the hippocampus in schizophrenia patients before and after surgery
下载PDF
导出
摘要 目的探讨精神分裂症患者海马磁共振质子波谱(MRS)的变化特点以及立体定向手术治疗对海马磁共振质子波谱的影响。方法应用磁共振质子波谱成像技术,对20例正常人和20例精神分裂症患者在手术治疗前、后检测双侧海马NAA/Cr和CHO/Cr的比值并进行统计分析。结果患者组在手术治疗前的NAA/Cr值低于正常对照组,患者组在手术治疗前的CHO/Cr值高于正常对照组(P<0.01)。患者组行手术治疗前与手术治疗后6个月时其双侧海马的NAA/Cr和CHO/Cr比值无显著差异(P>0.05)。结论精神分裂症患者的海马可能存在神经元的损害和细胞膜的代谢异常,立体定向手术对精神分裂症患者的细胞膜代谢无显著影响。 Objective To explore the features of proton magnetic resonance spectroscopy (^1H-MRS) of the hippocampus in schizophrenia patients before and after stereotactic neurosurgery. Methods ^1H-MRS was performed to determine NAA/Cr and CHO/Cr ratioson the bilateral hippocampal regions before and after stereotactic neurosurgery in 20 schizophrenia patients, with 20 healthy individuals as the controls. Results The NAA/Cr ratio in the hippocampal regions was significantly lower and the CHO/Cr ratio significantly higher in schizophrenia patients before the surgery than in the healthy controls (P〈0.01). The NAA/Cr and CHO/Cr ratios in the hippocampal regions underwent no significant changes in the patients after the surgeries (P〉0.05). Conclusion Neuronal and cell membrane metabolism impairment is present in the hippocampus of schizophrenia patients, and stereotactic neurosurgery does not produce obvious adverse effects on the cell membrane metabolism in the hippocampus of the patients.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第5期996-998,共3页 Journal of Southern Medical University
关键词 精神分裂症 海马 磁共振波谱学 schizophrenia hippocampus magnetic resonance spectroscopy
  • 相关文献

参考文献16

  • 1Pegues MP,Rogers LJ,Amend D,et al.Anterior hippocampal volume reduction in male patients with schizophrenia[J].Schizophr Res,2003,60:105-15.
  • 2Arnold SE.Cellular and molecular neuropathology of the parahippocampal region in schizophrenia[J].Ann N Y Acad Sci,2000,911:275-92.
  • 3Stauley JA,Pettegrew JW,Keshavan MS.Magnetic resonance spectroscopy in schizophrenia:methodological issue and findings part Ⅰ[J].Biol Psychiatry,1998,43:357-68.
  • 4Deicken RF,Zhou L,SchuffN,et al.Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy[J].Biol Psychiatry,1998,43:483-8.
  • 5Malin GS,Valenzuela M,Wen W,et al.Magnetic resonance spectroscopy and its application in psychiatry[J].Aust NZ J Psychiatry,2002,36(1):31-43.
  • 6Miyamoto S,Lamantia AS,Duncan GE,et al.Recent advance in the neurobiology of schizophrenia[J].Mol Interv,2003,3(1):27-39.
  • 7Mara C,Matide I,Elisabctta J,et al.Mean diffusitivity and fractional anisotropy histograms of patients with multiple sclerosis[J].AJNR,2001,22(5):952-8.
  • 8Fukuzako H,Takeuchi K,Hokazono Y,et al.Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia[J].Psychiatry Res,1995,61:193-200.
  • 9Delamiilieure P,Constans JM,Fernandez J,et al.Proton magnetic resonance spectroscopy (^1H-MRS) in schizophrenia; investigation of the right and left hippocampus,thalamus and prefrontai cortex[J].Schizophr Bull,2002,28:329-39.
  • 10Ross AJ,Sachdev PS.Magnetic resonance spectroscopy in cognitive research[J].Brain Rrs Rev,2004,44(2-3):83-102.

同被引文献24

  • 1牟君,谢鹏,杨泽松,杨德兰,吕发金,李勇,罗天友.初发抑郁症患者丘脑质子磁共振波谱分析[J].中国神经精神疾病杂志,2007,33(4):229-232. 被引量:9
  • 2李建军,林明方,孔祥泉,王桂华,蒋湘玲,郭敏.青年抑郁症患者基底节和丘脑3D ~1H-MRS研究[J].放射学实践,2007,22(7):679-682. 被引量:3
  • 3Brandao LA, Domingues RC. MR Spectroscopy of the Brain [M].天津:天津科技翻译出版公司,2005:前言.
  • 4Steoger A, Holsboer F. Nocturmal secretion ofprolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission [J]. Psychia try Res, 1997, 72(2): 812.
  • 5Berridge M J, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis[J]. Cell, 1989, 59(3): 411-9.
  • 6Ross BD. Biochemical considerations in 1H spectroscopy: glutamate and glutamine;myo-inositol and related metabolites [J]. NMR Biomed, 1991, 4: 59-63.
  • 7Moore GJ, Galloway MP. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders [J]. Psychopharmacol Bull, 2002, 36(2): 5-23.
  • 8Gruber S, Frey R, Mlynarik V, et al. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by ^1H-MRS at-3 Tesla [J]. Invest Radiol, 2003, 38 (7): 403 -8.
  • 9Coupland NJ, Ogilvie C J, Hegadoren KM, et al. Decreased prefrontal myo-inositol in major depressive disorder [J]. Biol Psychiat, 2005, 57: 1526-34.
  • 10Nicholl CR, Lincoln NB, Muncaster K, et al. Cognitions and poststroke depression[J]. Br J Clin Psychol, 2002, 41(Pt 3): 221-31.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部